Estimated reading time: 7 minutes Key Takeaways Meta invests £15bn in Scale AI to bolster its artificial intelligence ambitions. Scale AI remains operationally independent despite the substantial minority stake. Alexandr …
-
-
Estimated reading time: 6 minutes Key Takeaways Consumer optimism sees its first major boost in six months. Inflation worries are easing, driven by calmer supply chain conditions. Trade policy pauses …
-
Estimated reading time: 7 minutes Key Takeaways JBS made a highly anticipated debut on the NYSE, showcasing its expanding international influence. The listing consolidates JBS’s global position as a leader …
-
Estimated reading time: 5 minutes Key Takeaways United Airlines experienced a notable single-day decline of over 4%. Adobe and Halliburton show significant movement but lack specific data at this time. …
-
Estimated reading time: 5 minutes Key Takeaways Mortgage rates have dropped to a six-week low after four consecutive days of declines. This dip offers potential refinancing savings for current homeowners. …
-
Estimated reading time: 6 minutes Key Takeaways US airline shares have dropped substantially amid heightened Iran-Israel tensions. Sensitive energy markets led to a surge in oil prices, raising airline operating …
-
Estimated reading time: 7 minutes Key Takeaways Walmart and Amazon poised to launch stablecoins pegged to fiat currency. Potential for cost savings and loyalty incentives via blockchain-based transactions. Regulatory developments …
-
Estimated reading time: 5 minutes Key Takeaways Escalating tensions between Israel and Iran have caused a rapid surge in oil prices. Concerns about potential disruptions to Middle East oil supplies …
-
Estimated reading time: 7 minutes Key Takeaways June 2025 refinance rates have steadily fallen, boosting homeowner interest in refinancing. Economic and market dynamics, including the potential for Federal Reserve rate …
-
Estimated reading time: 5 minutes Key Takeaways Merck achieves a groundbreaking FDA approval expansion for Keytruda, specifically targeting head and neck cancer. This expansion introduces the first FDA-approved perioperative regimen …